Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

269
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
269
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

378
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
378
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

352
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
352
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

478
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
478
Shunt Admittances01:26

Shunt Admittances

506
Shunt admittances play a crucial role in the analysis of transmission lines, particularly for three-phase systems with neutral conductors. When a uniformly charged conductor is positioned above the Earth, it induces an equal but opposite charge on its surface. This interaction creates electric field lines between the conductor and the Earth.
To model this effect, the method of images is employed. This method involves replacing the Earth with an image conductor that mirrors the original...
506
Venous Return01:04

Venous Return

12.5K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total thyroidectomy for management of thyroid disease.

World journal of surgery·2000
Same author

Parathyroid cysts.

The Australian and New Zealand journal of surgery·1999
Same author

Quality of life as an outcome variable in oncology and surgery.

The Australian and New Zealand journal of surgery·1994
Same author

Do medical students remember multiple choice questions?

The Australian and New Zealand journal of surgery·1993
Same author

Computer assisted diagnosis of the acute abdomen.

The Australian and New Zealand journal of surgery·1993
Same author

Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management.

Cancer·1993

Related Experiment Video

Updated: Feb 11, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

10.7K

Peritoneo-venous shunts for malignant ascites

I R Gough

    The Australian and New Zealand Journal of Surgery
    |February 1, 1982
    PubMed
    Summary

    Le Veen peritoneo-venous shunts effectively managed malignant ascites in most patients, offering palliation for up to 15 months. This procedure is recommended for patients with uncontrollable malignant ascites and an expected survival exceeding one month.

    Area of Science:

    • Oncology
    • Gastroenterology
    • Surgical Innovation

    Background:

    • Malignant ascites is a common complication of advanced cancers, significantly impacting patient quality of life.
    • Uncontrolled malignant ascites presents a therapeutic challenge, often requiring palliative interventions.

    Purpose of the Study:

    • To evaluate the efficacy and safety of Le Veen peritoneo-venous shunts in managing uncontrollable malignant ascites.
    • To determine the suitability of peritoneo-venous shunting for patients with advanced malignancy.

    Main Methods:

    • A cohort of ten patients with uncontrollable malignant ascites underwent Le Veen peritoneo-venous shunt insertion.
    • Patient outcomes, including shunt function and survival, were monitored.

    Main Results:

    More Related Videos

    Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
    07:10

    Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

    Published on: June 18, 2020

    22.9K
    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
    08:32

    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

    Published on: February 22, 2019

    7.5K

    Related Experiment Videos

    Last Updated: Feb 11, 2026

    Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
    14:59

    Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

    Published on: October 14, 2022

    10.7K
    Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
    07:10

    Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

    Published on: June 18, 2020

    22.9K
    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
    08:32

    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

    Published on: February 22, 2019

    7.5K
    • The shunt successfully controlled ascites in five of seven patients until their death from malignancy (up to 15 months).
    • In surviving patients, shunts provided control for 6-7 months, with one requiring revision due to blockage but remaining functional post-replacement.
    • The procedure demonstrated a favorable safety profile in this small cohort.

    Conclusions:

    • Le Veen peritoneo-venous shunting is an effective treatment option for uncontrollable malignant ascites.
    • The procedure is indicated for patients with expected survival greater than one month, offering significant palliation.